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Abstract
Vibrio vulnificus secretes a hemolysin/cytolysin (VVH) that induces cytolysis in target cells. A detergent resistant membrane
domain (DRM) fraction of the cells after sucrose gradient centrifugation includes cholesterol-rich membrane microdomains
which have been called ‘‘lipid rafts’’. It was reported that some pore-forming toxins require association with DRM and/or
lipid rafts to exert their cytotoxicity. It has also been thought that cellular cholesterol is involved in VVH cytotoxicity because
VVH cytotoxicity was inhibited by pre-incubation with cholesterol. However, both cellular localization and mode of action of
VVH cytotoxicity remain unclear. In this study, we investigated the relationship between VVH localization on the cellular
membrane and its cytotoxicity. Oligomers of VVH were detected from DRM fractions by sucrose gradient ultracentrifugation
but all of these oligomers shifted from DRM fractions to non-DRM fractions after treatment with methyl-beta-cyclodextrin
(MbCD), a cholesterol sequestering agent. On the other hand, immunofluorescence analysis showed that VVH did not co-
localize with major lipid raft markers on cellular membrane of CHO cells. These data suggested that VVH localized at
membrane regions which are relatively abundant in cholesterol but which are not identical with lipid rafts. To determine the
linkage between localization and cytotoxicity of VVH, cytotoxicity was evaluated in MbCD-treated CHO cells. The
cytotoxicity of VVH was not decreased by the MbCD treatment. In addition, the amount of VVH oligomer did not decrease in
MbCD-treated CHO cells. Thus, we found that the amount of oligomer on cellular membrane is important for induction of
cytotoxicity, whereas localization to lipid rafts on the cellular membrane was not essential to cytotoxicity.
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Introduction
Vibrio vulnificus is an opportunistic pathogen that results in a high
mortality rate (.50%) in septicemia [1]. Primary septicemia in V.
vulnificus infection is caused by the ingestion of contaminated
seafood or through wound infection resulting from exposure
to contaminated seawater or marine products [2,3]. V. vulnificus
secretes a pore-forming toxin called Vibrio vulnificus hemolysin/
cytolysin (VVH) that is a possible virulence factor [4,5]. Most
studies of the cellular intoxication of VVH have focused on the
hemolytic mechanism. VVH monomer binds to cell membrane to
form SDS-resistant oligomers [6]. These oligomers form small ion-
permeable pores that induce hemolysis via colloid osmotic shock
[7]. Cholesterol neutralizes the hemolytic activity of VVH in a
concentration-dependent manner, and the VVH monomer was
converted into an oligomer by mixing with cholesterol [8]. There-
fore, cholesterol has been thought to be one of the cellular
receptors for VVH.
On cellular membranes, there are several microdomains termed
lipid rafts that are characteristically rich in cholesterol, sphingo-
lipid, glycosylphosphatidylinositol (GPI)-anchored proteins, Fas/
CD95, Src kinases, small G proteins, and heterotrimeric G
proteins. These elements are thought to serve as platforms for the
assembly of signaling complexes [9,10]. In addition, lipid rafts are
important for bacteria or viruses to penetrate to host cells [11,
12,13]. Lipid rafts are detected as detergent resistant membranes
(DRMs) by sucrose gradient ultracentrifugation, and DRMs are
characterized biochemically by their resistance to detergents, such
as Triton X-100, at low temperature [14,15]. Until recently, it had
been thought that DRMs and lipid rafts were the same. However,
it is now thought that DRMs are similar to lipid rafts, but not
identical. Because addition of Triton X-100 may induce not only
enhancement of liquid-ordered domain formation but also fusion
of existing lipid rafts, this treatment forms some large confluent
membrane aggregates in the cells [16,17]. Although analysis using
sucrose gradient ultracentrifugation is still controversial because of
the issues mentioned above, this method using detergent remains
in general use for separation of lipid rafts in cell membranes.
Recently, it was also suggested that lipid rafts could be classified
by their associated molecules. Shogomori et al. reported that
sphingomyelin-rich domains are distinct from GM1-rich domains
[18]. Fujita et al. reported GM3-rich domains did not co-exist with
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the localization of Vibrio parahaemolyticus thermostable direct
hemolysin (TDH) was shifted from DRM fractions to non-DRM
fractions by MbCD treatment, and that the cytotoxicity of TDH
to HeLa cells was decreased by this treatment [20]. On the other
hand, the localization and cytotoxicity of aerolysin, a pore-forming
toxin produced by Aeromonas hydrophila, were not affected by the
treatment with MbCD [21,22]. Thus, localization of pore-forming
toxins in their specific-DRMs might be important for these toxins
to exert cytotoxicity. However, to date, the localization of VVH in
target cell membrane has not been elucidated. In this study, we
investigated the linkage between localization and cytotoxicity of
VVH. We found that the VVH cytotoxicity was not affected by
MbCD-treatment in CHO cells, despite the fact that the VVH
fractions were shifted from the DRMs to non-DRMs in the cellular
membrane.
Results
VVH associates with DRMs
VVH may be localized at DRMs, cholesterol-rich microdo-
mains, because cholesterol is thought to be a cellular receptor for
VVH. However, binding and association of VVH on cellular
membranes remains unclear. To investigate the localization of
VVH on cellular membranes, VVH-treated CHO cells were lysed
with 1% Triton X-100 and lysate was fractionated by sucrose
gradient ultracentrifugation. VVH monomers and oligomers were
detected in both DRM and non-DRM fractions with Flotillin-1 or
TfR, which are known as major markers of lipid rafts or non-lipid
rafts, respectively (Fig. 1). It is known that VVH binds to cellular
membrane as a monomer and then forms oligomers by membrane
fluidity [8]. Our result indicates that monomers of VVH bind to
membrane regions in both DRM and non-DRM fractions, and
that these monomers then oligomerize in both regions.
MbCD changes the localization of VVH
We investigated whether MbCD changes the localization of
VVH or not. Oligomers of VVH are simultaneously associated
with Flotillin-1 and TfR in MbCD untreated cells. However, after
treatment with 8 mM MbCD to sequester cellular cholesterol, the
oligomer was not found in DRM fractions and was detected only
in non-DRM fractions (Fig. 2). These results indicated that the
sequestering of cholesterol changes the cellular localization of
VVH in CHO cells.
Localization and cytotoxicity of VVH are not affected by
SMase
It is well known that sphingomyelin is one of the major
components of lipid rafts [23]. Therefore, we investigated whether
or not the localization of VVH is affected by SMase, which
hydrolyzes sphingomyelin into ceramide and phosphorylcholine.
Unlike the case with MbCD, localization of VVH was unaffected
by SMase (Fig. 3). We used lysenin, which binds sphingomyelin
specifically and induces cytotoxicity, as a control for assessment of
effect of SMase. VVH could induce cytotoxicity in 100 mU/ml
SMase-treated cells (data not shown), whereas the percentage of
LDH release by lysenin was decreased from 76.664.1% to
0.2660. 4% in 100 mU/ml SMase-treated cells (data not shown).
It was apparent that the localization and cytotoxicity of VVH was
unaffected by treatment with SMase.
VVH does not co-localize with major lipid raft molecules
or a non-lipid raft molecule on cellular membrane
As shown in Fig. 2, VVH localization was redistributed in
MbCD-treated cells, but was not affected by SMase-treatment
(Fig. 3). In addition, many recent reports have shown that DRM
fractions separated by sucrose gradient ultracentrifugation are not
identical to lipid rafts [16,17]. To assess whether VVH localized at
lipid rafts on cellular membrane or not, the localization of VVH
on cellular membrane was investigated by immunofluorescence
analysis using flt-1, caveolin-1 (cav-1), or cholera toxin subunit B
(CTxB), which are known as major lipid raft marker molecules, or
TfR as a non-lipid raft marker molecule as the control. VVH did
not co-localize with any of these molecules (Fig. 4). These data
Figure 1. VVH associates with DRMs. CHO cells were incubated
with 5 mg/ml VVH at 37uC for 15 min. After being fractionated by
sucrose gradient ultracentrifugation, VVH, flotillin-1 (flt-1), and trans-
ferrin receptor (TfR) were detected by western blotting using specific
antibodies.
doi:10.1371/journal.pone.0026018.g001
Figure 2. MbCD changes the localization of VVH. CHO cells were
incubated with (+) or without (2) 8 mM MbCD at 37uC for 1 h. After
incubation, the cells were washed twice with DMEM and incubated with
5 mg/ml VVH at 37uC for 15 min. Cells were lysed, and fractionated.
VVH, flotillin-1 (flt-1), and transferrin receptor (TfR) were detected by
western blotting using specific antibodies.
doi:10.1371/journal.pone.0026018.g002
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lipid rafts detected by the marker molecules used in this study.
VVH apparently localizes at unique regions where these major
lipid raft and non-raft markers are not found.
Cholesterol sequestering did not affect VVH cytotoxicity
in most cell lines
The VVH did not localize at lipid rafts, which are cholesterol
rich membrane domains (Fig. 4). On the other hand, it was
reported previously that cholesterol sequestering could inhibit the
cytotoxicity of VVH in HeLa cells and HL-60 cells [24,25].
Therefore, cholesterol is thought to be a cellular receptor for
VVH. We investigated the effect of cholesterol sequestering on
VVH cytotoxicity using the LDH release assay in various cell lines
including HeLa cells. LDH is an enzyme confined to the
cytoplasm, and its extracellular presence reflects cell damage.
SLO, a well known cholesterol dependent cytolysin (CDC), was
used in this assay as a control [26,27]. As shown in Figure 5A, B,
and C, 8 mM MbCD has no effect on the percentage of LDH
release by VVH, whereas that by SLO was decreased significantly
in CHO cells (a Chinese hamster ovary cell line), J774A.1 cells (a
mouse reticulum cell sarcoma cell line), and Caco-2 cells (a human
colorectal adenocarcinoma cell line). These data indicate that
cholesterol sequestering did not affect VVH cytotoxicity in most
cell lines. In addition, the cytotoxicity of VVH was not affected by
MbCD in CHO cells (Fig. 5A), despite the fact that the
distribution of oligomers shifted from DRM fractions to non-
DRM fractions in 8 mM MbCD-treated CHO cells (Fig. 2). These
results indicate that the localization of VVH at DRMs is not
always necessary to exert its cytotoxicity. On the other hand, in
HeLa cells (a human cervical adenocarcinoma cell line), the
sequestering of cholesterol decreased the amount of LDH release
by SLO and VVH only in the 8 mM MbCD-treated cells (Fig. 5D).
These data suggest that effect of cholesterol sequestering on VVH
cytotoxicity varies by cell line.
HeLa cells are highly susceptible to sequestration of
cholesterol by MbCD
To compare the influence of MbCD between CHO cells and
HeLa cells, we measured the cellular cholesterol contents and the
percentage decrease of cholesterol in CHO and -HeLa cells
treated with 0, 2, or 8 mM of MbCD. The cholesterol content
(mg/1610
6 cells) in the HeLa cells without treatment with MbCD
was significantly higher than in the CHO cells, but fell significantly
in both cell lines to similar levels by treatment with 8 mM MbCD
(Fig. 6A). However, if we compare the cholesterol reduction
efficiency of MbCD between these two cell lines, the treatment
with 8 mM MbCD was more effective in the HeLa cells than in
the CHO cells, whereas the reduction efficiency at 2 mM MbCD
was almost the same in both cell lines (Fig. 6B). These findings
indicate that HeLa cells have a higher baseline cholesterol content,
and have a higher susceptibility to MbCD than CHO cells.
MbCD inhibits cytotoxicity by reducing VVH binding on
HeLa cells
As shown in Fig. 5D, 8 mM MbCD inhibited the cytotoxicity of
VVH in HeLa cells. To determine the inhibition mechanism of
VVH cytotoxicity in these cells, we evaluated the binding
efficiency and oligomer formation of VVH by measuring the
amount of oligomer of VVH on HeLa cells and -CHO cells
treated with 0, 2 or 8 mM of MbCD. The amount of oligomer
decreased only in 8 mM MbCD-treated HeLa cells (Fig. 7A), and
the monomer could not be detected in those cells (data not shown).
On the other hand, the amount of oligomer did not decrease in
8m MM bCD-treated CHO cells (Fig. 7A). It has previously been
reported that VVH first binds to the cellular membrane as
monomers and then these monomers are assembled to form
oligomers [8]. Our results indicated that the amount of oligomer
was decreased as a result of reduced monomer binding in 8 mM
MbCD-treated HeLa cells.
Next, we confirmed whether or not the decrease of oligomer by
the treatment of MbCD affected cytotoxicity of VVH in HeLa
cells. Reflecting the results of HeLa cells in Fig. 7A, the percen-
tage of LDH release by VVH decreased from 85.561.5% to
17.3%64.3% in 8 mM MbCD-treated HeLa cells, whereas VVH
cytotoxicity was not prevented in 2 mM MbCD-treated HeLa
cells and in 8 mM MbCD-treated CHO cells (Fig. 7B). This
demonstrates that 8 mM MbCD inhibits the cytotoxicity of VVH
by decreasing the binding of VVH to HeLa cells. Remarkably,
VVH induced cytotoxicity in 2 mM MbCD-treated HeLa cells,
but SLO, a well known CDC, did not (Fig. 7B).
Discussion
It was reported that several pore-forming toxins, such as
aerolysin and TDH, can associate with DRM fractions, as
determined by analysis using the sucrose gradient ultracentrifuga-
tion technique [20,21,22]. Aerolysin mainly associates with lipid
rafts using a GPI-anchor protein as a receptor [28]. The
localization of aerolysin was not affected by MbCD treatment
[21,22]. On the other hand, Matsuda et al. [20] reported that
TDH localizes at DRM fractions and non-DRM fractions equally,
and that all the detectable TDH was shifted to non-DRM fractions
by sucrose gradient analysis in MbCD-treated HeLa cells. They
also reported that TDH is shifted from DRM fractions to non-
DRM fractions in SMase-treated HeLa cells [20], and concluded
that TDH may localize at MbCD- and SMase-sensitive membrane
Figure 3. Localization and cytotoxicity of VVH are not affected
by SMase. CHO cells were incubated with (+) or without (2) 100 mU/
ml SMase at 37uC for 1 h. After incubation, the cells were washed twice
with DMEM and incubated with 5 mg/ml VVH at 37uC for 15 min. Cells
were lysed, and fractionated. VVH, flotillin-1 (flt-1), and transferrin
receptor (TfR) were detected by western blotting using specific
antibodies.
doi:10.1371/journal.pone.0026018.g003
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[20]. In our experiments, the localization of VVH shifted from
DRM fractions to non-DRM fractions in MbCD-treated CHO
cells, but not in SMase-treated CHO cells, unlike aerolysin and
TDH, respectively (Fig. 3). In addition, VVH did not co-localize on
the cellular membrane with either of three lipid raft marker
molecules or a control non-lipid raft marker by fluorescent
microscope analysis (Fig. 4). These results indicated that VVH
localized at membrane regions that were relatively abundant in
cholesterol, and which were included in DRM fractions by sucrose
gradient ultracentrifugation, but which were not identical with lipid
rafts on cellular membrane. Thus, the localization of VVH on
cellular membrane is possibly different from that of aerolysin or
TDH.
The localization of VVH was drastically shifted from DRM
fractions to non-DRM fractions by cholesterol sequestering with
8m M M bCD in Fig. 2. Although the percentage of cellular
cholesterol in CHO cells was decreased to 57.268.8% of the
control by treatment with 8 mM MbCD (Fig. 6B), the total
amount of VVH oligomer in these cells was not affected (Fig. 7A).
Furthermore, there was no change in cytotoxicity of VVH
between the MbCD-treated and the untreated cells at any
concentration of VVH (data not shown). These findings
demonstrate that cholesterol sequestering was able to influence
the localization of VVH, but not binding efficiency, oligomer
formation and cytotoxicity. Thus, it is clear that the most
important determinant for exertion of cytotoxicity by VVH is
the amount of oligomer on the cellular membranes.
It is well known that VVH binds to cellular membrane as a
monomer and then forms oligomers by membrane fluidity [8]. As
shown in Fig. 1, equal amounts of VVH monomers were detected
from both DRM and non-DRM fractions. In addition, VVH has
Figure 4. VVH does not co-localize with three major lipid raft molecules or a non-lipid raft molecule. CHO cells were fixed, and then
incubated with 5 mg/ml VVH. After washing the cells with PBS, the cells were incubated with anti-VVH and biotin- conjugated CTxB, anti-cav-1, anti-
flt-1 or anti-TfR. The cells were probed with Alexa 488-conjugated anti-rabbit anti-body (for VVH) and Alexa 546-conjugated streptavidin (for CTxB)o r
Alexa 546-conjugated anti-mouse anti-body (for cav-1 and flt-1). Images were obtained by FW4000 fluorescent microscopy.
doi:10.1371/journal.pone.0026018.g004
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HeLa cells (Fig. 5A, B, C and D). These data suggested that
cellular receptors for VVH exist in both DRMs and non-DRMs
equally in CHO cells, and that these receptors might be expressed
in various cell lines. Cholesterol is thought to be a cellular receptor
for VVH because its components are ubiquitously expressed on
cellular membranes in mammalian cells. Certainly, the cytotox-
icity of VVH on HeLa cells was prevented by 8 mM MbCD
treatment (Fig. 7B). The amount of oligomer was also decreased in
8m MM bCD-treated HeLa cells due to the decreased binding
efficiency of VVH on these cells (Fig. 7A). However, when we
compared the cholesterol contents between HeLa cells and CHO
cells after 8 mM MbCD treating, there was no difference in the
cholesterol contents in the two cell lines (Fig. 6A). These results
suggest that cholesterol is not the main receptor for VVH
cytotoxicity. In our experiment, the percentage of cellular
cholesterol was decreased to 36.364.3% of the control in 8 mM
MbCD-treated HeLa cells (Fig. 6B), and it is well known that
cellular cholesterol is essential to maintain membrane stability,
suggesting that such a severe decrease of cellular cholesterol by
8m MM bCD might cause disruption of membrane stability in the
HeLa cells. Therefore, a decrease in binding efficiency of VVH in
8m MM bCD-treated HeLa cells might be the main mechanism
for prevention of VVH cytotoxicity in the HeLa cells. Our
conclusion that cholesterol is not the main cellular receptor for
VVH is also supported by our experiment with SLO (Fig. 7B). The
cytotoxicity of SLO was inhibited in 2 mM MbCD-treated HeLa
cells but the cytotoxicity of VVH was not (Fig. 7B). These data also
suggested that the cellular cholesterol might not be directly
involved in the cytotoxic mechanism of VVH, and that VVH
might not be a CDC.
Taken together, we showed that the localization of VVH on the
cell membrane may be different from that of aerolysin and TDH.
In the future, bacterial pore-forming toxins such as VVH, TDH
and aerolysin may become useful tools for classification and/or
tracking of specific regions on cellular membrane.
Materials and Methods
Cell culture
Chinese hamster ovary (CHO) cells (ATCC, number CCL-61),
J774A.1 cells (ATCC, number TIB-67), Caco-2 cells (ATCC,
number HTB-37) and HeLa cells (ATCC, number CCL-2.2) were
grown in Dulbecco’s modified Eagle’s minimum essential medium
(DMEM; Gibco BRL Life Technologies, Rockville, MD) supple-
mented with 2 mM glutamine, 2 mM sodium pyruvate, and 10%
heat-treated fetal calf serum. Cells were incubated at 37uC under
5% CO2 in air in a humidified atmosphere.
Figure 5. Cholesterol sequestering did not affect VVH cytotoxicity in most cell lines. CHO (A), J774A.1 (B), Caco-2 (C) and HeLa cells (D)
were incubated with (+) or without (2) 8 mM MbCD at 37uC for 1 h. After washing the cells, the cells were incubated with 1 mg/ml of VVH (open bar)
for 3 h or 50 HU/ml of SLO (closed bar) for 1.5 h at 37uC. The cytotoxicity in these cells was assayed by the release of lactate dehydrogenase (LDH).
Data are represented as the mean 6 SD and represent more than three independent experiments, each in triplicate wells. *, analysis of variance and
Tukey’s test, P,0.01.
doi:10.1371/journal.pone.0026018.g005
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Methyl-b-cyclodextrin (MbCD), sphingomyelinase (SMase),
streptolysin-O (SLO), biotin conjugated cholera toxin subunit B
(CTxB) and Lysenin were purchased from Sigma (St. Louis, MO).
Alexa 488-conjugated anti-rabbit anti-body, Alexa 546-conjugated
anti-mouse anti-body and Alexa 546-conjugated streptavidin were
purchased from Molecular Probes (Eugene, OR). The presence of
actin, flotillin-1, transferrin receptor (TfR), caveoline-1 and VVH
were detected using anti-actin monoclonal antibody clone C4
(Chemicon International Inc., Temecula, CA ), anti-flotillin-1
monoclonal antibody clone 18 (BD Biosciences, San Jose, CA),
anti-TfR monoclonal antibody clone H68.4 (Zymed Laboratories
Inc., South San Francisco, CA), anti-caveolin-1 monoclonal
antibody clone 2297 (BD Biosciences, San Jose, CA) and anti-
VVH polyclonal antibody, respectively.
Purification of VVH
VVH was purified from the culture supernatant of the V.
vulnificus K1 strain following the method of Oh et al. [29]. The
protein concentration of each fraction was checked by optical
density at 280 nm, and fractions with a high concentration of
protein were used for sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). The gel was stained with staining
solution containing 0.5% Coomassie brilliant blue R-250. Purified
VVH was observed as a single band. VVH-containing fractions
were dialyzed in 10 mM glycine buffer (pH 9.8)–150 mM NaCl at
4uC for 16 h. The dialyzed fractions were pooled as the purified
VVH. The specific activity of purified VVH was 70,000 hemolytic
units/mg (HU/mg), which was confirmed by examining the
hemolytic activity against mouse erythrocytes.
Isolation of DRMs
CHO cells were seeded in 8-cm tissue culture dishes at 2.5610
6
cells/dish. After 48 h, the cells were washed twice in DMEM and
then incubated in medium containing 8 mM MbCD or 100 mU/
ml SMase for 1 h at 37uC. The cells wererinsed and then incubated
with 5 mg/ml VVH at 37uC for 15 min. To detect the monomer,
cells were incubated for 1 h at 4uC with the same concentration of
VVH. After incubation, the cells were lysed with 700 ml of lysis
buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl) supplemented
with 1% Triton X-100 and a protease inhibitor mixture. Cells were
scraped and left for 30 min on ice. After centrifugation at 8006g for
10 min, 500 ml of the postnuclear supernatant was mixed with
500 ml of 80% sucrose (wt/vol) in ice-cold lysis buffer without
detergent and placed at the bottom of Hitachi 5PA ultracentrifuge
tubes. The samples were overlaid with 2 ml of 30% sucrose and
1 ml of 5% sucrose and centrifuged (Hitachi koki, Tokyo, Japan) at
170,0006g for 18 h. Following centrifugation, eight fractions of
500 ml each were collected, starting at the top of the gradient. A
distinct Triton X-100-insoluble whitish band that floated to the 5–
30% interface was designated the DRMs fraction. The whole
procedure was performed at 0–4uC. Aliquots of each fraction were
boiled in SDS-PAGE sample buffer (0.01% bromophenol blue,
125 mM Tris-HCl, 20% glycerol, and 4% SDS) containing
16.5 mM dithiothreitol, loaded onto SDS-PAGE (10% polyacryl-
amide gel), and transferred to an Immobilon-P transfer membrane
(Millipore Corporation, Bedford, MA) for 60 min at 15 V. Proteins
on the blots were detected using specific antibodies and visualized
using an enhanced chemiluminescence (ECL) system (Amersham
Pharmacia Biotech, Piscataway, NJ) according to the manufactur-
er’s protocol.
Cytotoxicity assay
Cytotoxicity was determined using a lactate dehydrogenase
(LDH) release assay. Cells were seeded in 24-well tissue-culture
plates at 1610
5 cells/well. After 48 h, the cells were washed twice
with DMEM, and then replaced with indicated concentrations of
MbCD or indicated concentrations of SMase. After incubation
with MbCD or SMase for 1 h at 37uC, the cells were washed twice
with DMEM for VVH or PBS for SLO. The VVH or SLO was
Figure 6. HeLa cells are highly susceptible to sequestration of cholesterol by MbCD. (A) Contents of cellular cholesterol were determined
as described in ‘‘Materials and methods’’. Gray bar indicates CHO cells, and shade bar indicates HeLa cells. *, P,0.05. **, P,0.01. #, P,0.01.
(B) Percentage of cellular cholesterol was determined as described in ‘‘Materials and methods’’. Gray bar indicate CHO cells, and shade bar indicate
HeLa cells. *, P,0.01. #, P,0.05.
doi:10.1371/journal.pone.0026018.g006
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respectively. Then aliquots of medium samples (sample LDH)
were assayed for LDH activity using pyruvate as a substrate. Cells
treated with MbCD or SMase were used to assess background
LDH activity. The percentage of LDH release was calculated
as (sample LDH2background LDH)/(total LDH2background
LDH)6100.
Oligomerization assay
Cells were seeded in 6-well tissue-culture plates at 5610
5 cells/
well. After 48 h, the cells were washed twice with DMEM, and
then replaced with or without indicated concentrations of MbCD
for 1 h at 37uC. The cells were incubated with 5 mg/ml of VVH
for 15 min at 37uC and then extracted with lysis buffer
supplemented with 1% Triton X-100 and a protease inhibitor
mixture. VVH oligomer and cellular actin were detected by
western blotting using antibodies against anti-VVH and anti-actin.
The band intensity of these proteins was measured using NIH
Image J software. Amount of oligomer was calculated by dividing
the band intensity of oligomer by that of actin.
Fluorescent microscope analysis
CHO cells were fixed with 3% (wt/vol) paraformaldehyde for
15 min. the cells incubated with 5 mg/ml VVH at 37uC for
15 min. After washing with PBS, the cells were incubated with
anti-VVH and, anti-caveolin-1, anti-flotillin-1, biotin-conjugated
cholera toxin subunit B (CTxB), or anti-TfR at room temp for
45 min. After washing with PBS, the cells were incubated with
Alexa 488-conjugated anti-rabbit anti-body and Alexa 546-
conjugated anti-mouse anti-body or Alexa 546-conjugated strep-
tavidin at room temp for 45 min. Leica FW4000 microscope was
used for fluorescent microscopy.
Measurement of cholesterol contents
Cellular cholesterol contents were assayed spectrophotometri-
cally using a Cholesterol E-Test Wako. (Wako, Osaka, Japan).
Briefly, after treatment with MbCD, the cells were washed twice
with 1 ml of cold PBS, and then lysed with lysis buffer. Six
hundred fifty microliters of the cell lysate was mixed with 100 mlo f
the cholesterol assay kit buffer solution and then this mixture was
further mixed with 750 ml of concentration enzyme mix solution.
Samples were incubated for 5 min at 37uC prior to measuring
absorbance at 600 nm. The cholesterol contents were determined
as follows: (measured fluorescence of sample/fluorescence of
standard cholesterol)6200. The percentage of remaining choles-
terol after pretreatment with MbCD was determined as follows:
(measured fluorescence of treated cells obtained from a standard
curve/total fluorescence of untreated cells)6100.
Figure 7. MbCD inhibits cytotoxicity by reducing VVH binding on HeLa cells. (A) Indicated concentrations of MbCD-untreated or -treated
HeLa or CHO cells were incubated with 5 mg/ml of VVH for 15 min at 37uC and then the cells were lysed. The VVH oligomer was detected from cell
lysate with anti-VVH polyclonal antibody by western blotting. The amount of oligomer was calculated as described in ‘‘Materials and methods’’.
*, P,0.01. (B) HeLa cells were incubated with indicated concentrations of MbCD or without at 37uC for 1 h. After incubation, the cells were incubated
with 1 mg/ml of VVH (open bar) for 3 h or 50 HU/ml of SLO (closed bar) for 1.5 h at 37uC. The cytotoxicity in these cells was assayed by the release of
LDH. Data are represented as the mean 6 SD and represented three independent experiments, each in triplicate wells. *, P,0.01.
doi:10.1371/journal.pone.0026018.g007
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All results are shown as means 6 SD (n=3). For multiple
comparisons of data, we used one-way ANOVA followed by
Tukey’s test; P,0.01 was considered statistically significant. Data
from studies with only two groups were analyzed by Student’s t test
for equal variance or Welch’s t-test for unequal variance after
Bartlett’s test.
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